Drugs / IV iron
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03214627 | Dec 2018 → May 2019 | anemia, end stage renal failure | Vifor Fresenius Medical Care Renal Pharma | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IV iron | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03214627 ↗ |